Client Service, Business Growth Remain Top Priority
Five members of McGuireWoods Consulting’s Atlanta office were recognized in the James Magazine’s 2018 “Top Lobbyist” issue.
McGuireWoods Consulting’s in-house advocacy and mobilization team, MWCAdvocacy, continues to grow, strategically expanding its depth of experience. This summer, three new hires were made to address specific client needs.
Chris Nolen, a senior vice president in McGuireWoods Consulting’s state government relations practice, recently received administration appointments by Virginia Gov. Ralph Northam and Virginia House of Delegates Speaker Kirk Cox.
Virginia Gov. Ralph Northam announced on Aug. 29 that Micron Technology plans to expand its Manassas plant, spending $3 billion and adding 1,100 high-paying jobs by 2030.
In recent years, state emissions credit programs and policy have sought to incentivize only renewable electricity generation, leaving out other sources of zero-emissions generation.
This Week: House and Senate Work to Avoid Government Shutdown; Legislation on Gag Clauses Moving; Oral Arguments on ACA Individual Mandate Court Case Held
Your weekly North Carolina political news report.
This week: Senate Commerce Committee advances science and technology policy nominees, House and Senate Committees question social media executives, net neutrality still controversial, House Panel discusses apprenticeship expansion
This week: House Committee to look at emerging transportation technologies, congress intensifying its response to robocalls and California passes initial revisions to new privacy law.
The House Ways and Means Committee passed several measures to expand tax-advantaged health savings accounts (HSA).
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Tax Policy Update Team.
On June 22, the House of Representatives concluded two weeks of voting on opioid legislation by approving a package that combines dozens of individual opioid-related bills that the House had approved over the past two weeks.